Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01129115 · ClinicalTrials.gov registry record · Early Phase 1

Dose Response Study of Aerobic Exercise in Older Adults

A Early Phase 1 study of Alzheimers Disease, sponsored by Jeff Burns, MD.

Completed
Registry status
Early Phase 1
Development phase
101
Enrollment target
1
Study location

NCT01129115: Completed Early Phase 1 study of Alzheimers Disease, sponsored by Jeff Burns, MD.

NCT01129115 is a Early Phase 1 study of Alzheimers Disease that has completed, run by Jeff Burns, MD. The registered enrollment target is 101 participants, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01129115, a Early Phase 1 study of Alzheimers Disease, has completed, sponsored by Jeff Burns, MD.

COMPLETED
Registry status
Early Phase 1
Development phase
101 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, 26-week study of supervised exercise assessing three doses of exercise in sedentary individuals 65 years of age and over with age-related cognitive changes. A total of 100 subjects (n=25 in each of four groups) will be randomized to a non-aerobic control group, 75 minutes, 150 minutes, or 225 minutes a week of moderate intensity aerobic exercise spread over 3 to 5 days a week for 26 weeks. These exercise doses represent 50%, 100%, or 150% of the recommended exercise dose. Participants will be directly supervised during all exercise sessions for the first two months after which direct supervision will occur during at least one session a week. This is intended to provide increased flexibility while also maintaining direct contact with the participant to enhance adherence. Aerobic fitness, physical function, and cognition will be assessed at baseline and 26 weeks to examine the dose-response relationships.

Conditions Studied

Alzheimers Disease

Interventions

  • BEHAVIORAL Nonexercise control group
  • BEHAVIORAL Aerobic Exercise Group 1
  • BEHAVIORAL Aerobic Exercise Group 2
  • BEHAVIORAL Aerobic Exercise Group 3

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2010-05
Est. Completion 2014-04
Phase Early Phase 1

Sponsor

Jeff Burns, MD

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01129115

The ClinicalTrials.gov registry entry for NCT01129115 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (98% lower). The listed sponsor is Jeff Burns, MD, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 4 interventions - of which Nonexercise control group is the first listed.

NCT01129115 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT01129115 about?

NCT01129115 is a clinical study titled "Dose Response Study of Aerobic Exercise in Older Adults". This is a randomized, 26-week study of supervised exercise assessing three doses of exercise in sedentary individuals 65 years of age and over with age-related cognitive changes. A total of 100 subjects (n=25 in each of four groups) will be randomized to a non-aerobic control group, 75 minutes, 150 ...

What is the current status of trial NCT01129115?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 101 participants. The study started on 2010-05. Estimated completion is 2014-04.

What conditions does trial NCT01129115 study?

This clinical trial studies the following conditions: Alzheimers Disease.

What interventions are being tested in trial NCT01129115?

The interventions under investigation include: Nonexercise control group (BEHAVIORAL), Aerobic Exercise Group 1 (BEHAVIORAL), Aerobic Exercise Group 2 (BEHAVIORAL), Aerobic Exercise Group 3 (BEHAVIORAL).

Who is sponsoring clinical trial NCT01129115?

This trial is sponsored by Jeff Burns, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01129115 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimers Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimers Disease

All registered trials for this condition

Kansas

All trials with a study site in Kansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.